In contrast, Myr (300 mg/kg) treatment rescued (p < 0.01) the reduction in PI3K, P-IRS-1, P-Akt, and GLUT4 (in the membrane) expressions in the skeletal muscle of T2D rats (Figure 8b). Here, SLC2A4 is linked to type 2 diabetes mellitus.